US EditionPublished • loading... • Updated
Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Hold” from Analysts
Summary by americanbankingnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Hold” from Analysts
Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) has received a consensus rating of “Hold” from the six research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. The […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
